RESUMEN
Focused ion beam (FIB) milling has been used to fabricate magnetic nanostructures (wires, squares, discs) from single magnetic layers (Co, permalloy) and spin-valve (permalloy/Cu/Co) multilayers (thicknesses 5-50 nm) prepared by ion beam sputtering deposition. Milled surfaces of metallic thin films typically exhibit residual roughness, which is also transferred onto the edges of the milled patterns. This can lead to domain wall pinning and influence the magnetization behaviour of the nanostructures. We have investigated the milling process and the influence of the FIB parameters (incidence angle, dwell time, overlap and ion beam current) on the roughness of the milled surface. It has been found that the main reasons for increased roughness are different sputter yields for various crystallographic orientations of the grains in polycrystalline magnetic thin films. We have found that the oblique ion beam angle, long dwell time and overlap < 1 are favourable parameters for suppression of this intrinsic roughness. Finally, we have shown how to determine the ion dose necessary to mill through the whole thin film up to the silicon substrate from scanning electron microscopy (SEM) images only.
RESUMEN
An equation for predicting endogenous creatinine clearance (CrCl) in adults and children (with both stable and unstable renal function) from serum creatinine concentration is presented. The predictions are compared with four other available estimating methods, bases on values in 110 subjects with renal impairment of widely differing degrees. In patients with stable and with unstable renal function the corelaion between measured and predicted CrCl was better with the new equation. In patients with rapid changing renal function the new equation resulted in accurate predictions CrCl within a few hours after the change, as opposed to several with the other methods. The elimination rate constant of the aminoglycoside antibiotic amikacin correlated more precisely with CrCl values estimated from the new equation that with those measured doing 24 hr or with the other prediction methods.
Asunto(s)
Composición Corporal , Creatinina/metabolismo , Lesión Renal Aguda/metabolismo , Adolescente , Adulto , Anciano , Amicacina/administración & dosificación , Amicacina/metabolismo , Amicacina/orina , Creatinina/sangre , Creatinina/orina , Femenino , Humanos , Inyecciones Intravenosas , Riñón/fisiología , Riñón/fisiopatología , Masculino , Tasa de Depuración Metabólica/efectos de los fármacos , Persona de Mediana Edad , Probabilidad , Análisis de Regresión , Grosor de los Pliegues CutáneosRESUMEN
Magnetic vortices are characterized by the sense of in-plane magnetization circulation and by the polarity of the vortex core. With each having two possible states, there are four possible stable magnetization configurations that can be utilized for a multibit memory cell. Dynamic control of vortex core polarity has been demonstrated using both alternating and pulsed magnetic fields and currents. Here, we show controlled dynamic switching of spin circulation in vortices using nanosecond field pulses by imaging the process with full-field soft X-ray transmission microscopy. The dynamic reversal process is controlled by far-from-equilibrium gyrotropic precession of the vortex core, and the reversal is achieved at significantly reduced field amplitudes when compared with static switching. We further show that both the field pulse amplitude and duration required for efficient circulation reversal can be controlled by appropriate selection of the disk geometry.
Asunto(s)
Antibacterianos/uso terapéutico , Infecciones por Pseudomonas/tratamiento farmacológico , Animales , Carbenicilina/uso terapéutico , Ácidos Carboxílicos/uso terapéutico , Modelos Animales de Enfermedad , Sinergismo Farmacológico , Femenino , Gentamicinas/uso terapéutico , Inmunosupresores , Penicilinas/uso terapéutico , Ratas , Tiofenos/uso terapéuticoAsunto(s)
Androstanos/farmacología , Anestesia , Fármacos Neuromusculares Despolarizantes/farmacología , Fármacos Neuromusculares no Despolarizantes/farmacología , Adolescente , Adulto , Anciano , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pancuronio/farmacología , Respiración/efectos de los fármacosAsunto(s)
Dermatomicosis/genética , Adulto , Animales , Enfermedades de los Gatos/transmisión , Gatos , Niño , Dermatomicosis/diagnóstico , Dermatomicosis/veterinaria , Femenino , Humanos , Masculino , MicrosporumAsunto(s)
Infecciones por Escherichia coli/tratamiento farmacológico , Gentamicinas/uso terapéutico , Tolerancia Inmunológica , Penicilinas/uso terapéutico , Animales , Azatioprina/uso terapéutico , Carbenicilina/uso terapéutico , Sinergismo Farmacológico , Hidrocortisona/uso terapéutico , Terapia de Inmunosupresión , Pielonefritis/tratamiento farmacológico , RatasRESUMEN
The therapeutic efficacy of gentamicin given once or three times a day was compared in a model of experimental renal infection in rats. The same amount of gentamicin given either in a single injection or three injections a day produced no statistically significant difference in the treatment of incipient infection. The effect of this mode of administration on advanced infection depended on the length of the therapy. After five days, administration of the same dose given in a single injection or three injections did not result in significant differences. After ten days the therapy proved more effective when gentamicin was injected three times a day. In comparison a single daily dose, amounting to two thirds of the total dose when given three times a day every eight hours, revealed after five days of therapy a statistically significantly lower bacterial count in the kidney than three daily injections of gentamicin.